Holowesko Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,314,343
Closed -$117M 35
2017
Q1
$117M Buy
1,314,343
+72,000
+6% +$5.92M 7.01% 2
2016
Q4
$87.9M Buy
1,242,343
+64,800
+6% +$4.83M 6.14% 4
2016
Q3
$93M Buy
1,177,543
+75,800
+7% +$6.47M 8.32% 2
2016
Q2
$100M Sell
1,101,743
-250,000
-18% -$21.2M 8.41% 2
2016
Q1
$115M Buy
1,351,743
+66,000
+5% +$4.91M 8.33% 1
2015
Q4
$102M Hold
1,285,743
6.62% 3
2015
Q3
$90.5M Buy
1,285,743
+141,200
+12% +$11.6M 6.3% 2
2015
Q2
$103M Buy
1,144,543
+80,000
+8% +$7.71M 6.41% 2
2015
Q1
$107M Buy
1,064,543
+80,000
+8% +$8.07M 8.35% 1
2014
Q4
$99M Hold
984,543
8.67% 2
2014
Q3
$94.7M Buy
984,543
+20,000
+2% +$1.9M 7.42% 1
2014
Q2
$89.9M Hold
964,543
5.44% 3
2014
Q1
$80.2M Buy
964,543
+5,000
+0.5% +$405K 4.69% 5
2013
Q4
$80.4M Buy
959,543
+332,500
+53% +$27.1M 5.71% 4
2013
Q3
$46.6M Sell
627,043
-29,957
-5% -$2.25M 4.79% 6
2013
Q2
$52.1M Buy
+657,000
New +$52.7M 4.24% 7

Other funds holding MJN

Holowesko Partners's MJN Position: Q2 2017 in Review

Holowesko Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 1,314,343 shares — an estimated $117M sold.

Holowesko Partners first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $117M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Holowesko Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Holowesko Partners sold 1,314,343 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $117M.
  • Holowesko Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Holowesko Partners's Mead Johnson Nutrition Company position peaked at $117M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Holowesko Partners's 13F filing for Q2 2017, filed 10 Aug 2017.